In Mouse Model Of Down Syndrome, Formoterol Improves Cognitive Function

An existing FDA-approved drug improves cognitive function in a mouse model of Down syndrome, according to a new study by researchers at the Stanford University School of Medicine. The drug, an asthma medication called formoterol, strengthened nerve connections in the hippocampus, a brain center used for spatial navigation, paying attention and forming new memories, the study said. It also improved contextual learning, in which the brain integrates spatial and sensory information...
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Pediatrics / Children's Health Source Type: news